TRIAZOLAM

TRIAZOLAM was reported 4042 times

TRIAZOLAM is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 PURPURA SENILE 11 0.0902
1 ACQUIRED AMINOACIDURIA 3 0.0732
2 TARSAL TUNNEL SYNDROME 10 0.0455
3 PLATELET AGGREGATION INHIBITION 3 0.0326
4 APPLICATION SITE INJURY 6 0.0316
5 IN VITRO FERTILISATION 5 0.0276
6 POSTOPERATIVE DELIRIUM 5 0.0253
7 EYE HAEMATOMA 6 0.0228
8 ALCOHOL INTERACTION 42 0.0216
9 HYPONATRAEMIC SYNDROME 6 0.0186
10 DISSOCIATIVE DISORDER 13 0.0180
11 CARDIOACTIVE DRUG LEVEL DECREASED 3 0.0175
12 SOPOR 208 0.0157
13 SICCA SYNDROME 3 0.0155
14 REDUCED FACIAL EXPRESSION 15 0.0148
15 ACTIVATION SYNDROME 5 0.0145
16 CERVICAL MYELOPATHY 3 0.0122
17 RESORPTION BONE INCREASED 10 0.0122
18 GINGIVAL EROSION 3 0.0116
19 HYPOURICAEMIA 3 0.0103
20 HYPORESPONSIVE TO STIMULI 12 0.0102
21 VESTIBULAR DISORDER 12 0.0098
22 VICTIM OF SEXUAL ABUSE 5 0.0095
23 ELECTROCARDIOGRAM T WAVE INVERSION 21 0.0095
24 INTELLECTUAL DISABILITY 14 0.0092
25 APPLICATION SITE ULCER 6 0.0085
26 SMALL CELL LUNG CANCER STAGE UNSPECIFIED 3 0.0082
27 DIVERTICULITIS INTESTINAL HAEMORRHAGIC 3 0.0078
28 SUBSTANCE DEPENDENCE 5 0.0074
29 POTENTIATING DRUG INTERACTION 24 0.0071
30 PLACENTA PRAEVIA 5 0.0064
31 EXPOSURE VIA BODY FLUID 5 0.0064
32 LABELLED DRUG-DRUG INTERACTION ISSUE 9 0.0062
33 LABELLED DRUG-FOOD INTERACTION MEDICATION ERROR 3 0.0060
34 CRANIAL NERVE DISORDER 4 0.0057
35 LIP EROSION 4 0.0055
36 VERTIGO POSITIONAL 9 0.0051
37 BRADYPHRENIA 33 0.0050
38 ORAL MUCOSA EROSION 6 0.0049
39 OPEN WOUND 5 0.0045
40 HEAT ILLNESS 3 0.0044
41 CARBON DIOXIDE INCREASED 6 0.0044
42 INTENTIONAL SELF-INJURY 87 0.0043
43 DRUG ABUSE 336 0.0040
44 CHLAMYDIAL INFECTION 3 0.0040
45 DROWNING 4 0.0040
46 QUADRIPLEGIA 8 0.0039
47 FULMINANT TYPE 1 DIABETES MELLITUS 4 0.0039
48 ADJUSTMENT DISORDER 5 0.0038
49 GINGIVAL INFECTION 3 0.0037
50 PERIORBITAL HAEMATOMA 3 0.0036
51 THROMBOPHLEBITIS SUPERFICIAL 11 0.0036
52 OESOPHAGEAL PERFORATION 3 0.0036
53 ADRENOCORTICOTROPIC HORMONE DEFICIENCY 3 0.0034
54 FANCONI SYNDROME ACQUIRED 6 0.0034
55 OSTEOMALACIA 5 0.0032
56 DISINHIBITION 5 0.0031
57 BLOOD CHLORIDE DECREASED 8 0.0031
58 BONE MARROW DEPRESSION 3 0.0031
59 DUODENAL PERFORATION 3 0.0031
60 BRAIN STEM INFARCTION 3 0.0029
61 CONCOMITANT DISEASE AGGRAVATED 18 0.0029
62 RHONCHI 4 0.0029
63 HYPOPITUITARISM 5 0.0029
64 NON-CARDIOGENIC PULMONARY OEDEMA 3 0.0028
65 HYPERPARATHYROIDISM SECONDARY 7 0.0028
66 PRE-EXISTING CONDITION IMPROVED 17 0.0027
67 DEMENTIA WITH LEWY BODIES 3 0.0027
68 NEUROLEPTIC MALIGNANT SYNDROME 32 0.0027
69 SECONDARY ADRENOCORTICAL INSUFFICIENCY 4 0.0026
70 HYPOPROTEINAEMIA 5 0.0026
71 AREFLEXIA 7 0.0026
72 PYELONEPHRITIS ACUTE 5 0.0025
73 PNEUMONIA INFLUENZAL 3 0.0025
74 MALLORY-WEISS SYNDROME 3 0.0024
75 GLUCOSE URINE PRESENT 3 0.0024
76 MYOCARDIAL ISCHAEMIA 26 0.0023
77 BIPOLAR I DISORDER 5 0.0023
78 LYMPHOCYTE PERCENTAGE DECREASED 3 0.0022
79 ASPHYXIA 18 0.0022
80 STUPOR 7 0.0022
81 NEPHROGENIC ANAEMIA 10 0.0022
82 CEREBELLAR HAEMORRHAGE 3 0.0021
83 ALTERED STATE OF CONSCIOUSNESS 45 0.0021
84 COMPLETED SUICIDE 172 0.0021
85 BRADYKINESIA 12 0.0020
86 VENTRICULAR EXTRASYSTOLES 21 0.0020
87 THYROIDITIS 6 0.0020
88 HYPOPHYSITIS 4 0.0020
89 REBOUND ACID HYPERSECRETION 6 0.0020
90 SUICIDE ATTEMPT 119 0.0020
91 DILATATION VENTRICULAR 4 0.0019
92 BUNDLE BRANCH BLOCK LEFT 8 0.0019
93 LANGUAGE DISORDER 4 0.0018
94 SKULL FRACTURE 3 0.0018
95 COSTOCHONDRITIS 3 0.0018
96 INTENTIONAL OVERDOSE 118 0.0018
97 DISSOCIATION 14 0.0018
98 PATHOLOGICAL GAMBLING 3 0.0018
99 RESPIRATORY ACIDOSIS 7 0.0018
100 PSYCHOMOTOR RETARDATION 5 0.0018
101 GASTROINTESTINAL HYPOMOTILITY 4 0.0018
102 SEROTONIN SYNDROME 34 0.0018
103 BLOOD LOSS ANAEMIA 4 0.0018
104 PHLEBITIS 9 0.0018
105 BUNDLE BRANCH BLOCK RIGHT 8 0.0017
106 HYPOKINESIA 25 0.0017
107 DIABETES INSIPIDUS 4 0.0017
108 TORSADE DE POINTES 13 0.0017
109 SELF INJURIOUS BEHAVIOUR 5 0.0016
110 BRAIN NATRIURETIC PEPTIDE INCREASED 5 0.0016
111 IMPULSIVE BEHAVIOUR 6 0.0016
112 ENDODONTIC PROCEDURE 4 0.0016
113 SEDATION COMPLICATION 4 0.0016
114 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 16 0.0016
115 CONVERSION DISORDER 3 0.0015
116 CONCOMITANT DISEASE PROGRESSION 3 0.0015
117 HYPERPHAGIA 6 0.0015
118 PERFORMANCE STATUS DECREASED 7 0.0015
119 BLOOD CREATINE PHOSPHOKINASE INCREASED 43 0.0015
120 ABDOMINAL RIGIDITY 4 0.0015
121 BREAST DISORDER 3 0.0015
122 CHEST INJURY 3 0.0014
123 SUICIDAL BEHAVIOUR 6 0.0014
124 POISONING 18 0.0014
125 BLEPHAROSPASM 9 0.0014
126 RENAL TUBULAR DISORDER 4 0.0014
127 HAEMORRHAGE SUBCUTANEOUS 5 0.0014
128 GLOSSITIS 5 0.0014
129 HEPATIC ENCEPHALOPATHY 13 0.0014
130 PERIODONTITIS 3 0.0014
131 BLOOD PARATHYROID HORMONE INCREASED 4 0.0014
132 MIOSIS 11 0.0014
133 ASPIRATION 15 0.0014
134 LUMBAR SPINAL STENOSIS 4 0.0014
135 FEMORAL NECK FRACTURE 7 0.0014
136 DELUSION 21 0.0014
137 THORACIC VERTEBRAL FRACTURE 4 0.0014
138 CARDIAC FAILURE ACUTE 9 0.0013
139 HEPATITIS FULMINANT 4 0.0013
140 FEELING DRUNK 10 0.0013
141 FEAR OF DEATH 3 0.0013
142 DIVERTICULUM INTESTINAL HAEMORRHAGIC 3 0.0013
143 HAEMATOCRIT INCREASED 3 0.0013
144 TOXICITY TO VARIOUS AGENTS 220 0.0013
145 APHTHOUS STOMATITIS 3 0.0013
146 DEPRESSED LEVEL OF CONSCIOUSNESS 51 0.0013
147 NECK SURGERY 3 0.0013
148 VITAMIN D DECREASED 11 0.0013
149 URINARY INCONTINENCE 38 0.0013
150 SUSPECTED SUICIDE 6 0.0013
151 ELECTROCARDIOGRAM QT PROLONGED 46 0.0013
152 ABDOMINAL ADHESIONS 4 0.0013
153 PSYCHOMOTOR HYPERACTIVITY 21 0.0013
154 BLOOD LACTATE DEHYDROGENASE INCREASED 20 0.0013
155 LACUNAR INFARCTION 3 0.0013
156 RADIUS FRACTURE 3 0.0012
157 HUMERUS FRACTURE 6 0.0012
158 ATELECTASIS 12 0.0012
159 SKIN EROSION 4 0.0012
160 INCOHERENT 8 0.0012
161 HORMONE LEVEL ABNORMAL 6 0.0012
162 SOMNAMBULISM 8 0.0012
163 DENTAL OPERATION 3 0.0012
164 METABOLIC DISORDER 7 0.0012
165 SLEEP APNOEA SYNDROME 23 0.0012
166 PERSECUTORY DELUSION 3 0.0012
167 COMA 57 0.0012
168 HAEMODIALYSIS 10 0.0012
169 CEREBRAL HAEMATOMA 4 0.0012
170 DERMATOMYOSITIS 3 0.0012
171 CANCER PAIN 3 0.0012
172 BLOOD ALKALINE PHOSPHATASE INCREASED 29 0.0012
173 PHYSICAL DECONDITIONING 3 0.0012
174 PNEUMONIA ASPIRATION 29 0.0012
175 CATHETER SITE PAIN 3 0.0012
176 PSYCHOMOTOR SKILLS IMPAIRED 3 0.0011
177 DEPRESSIVE SYMPTOM 4 0.0011
178 HYPERLACTACIDAEMIA 3 0.0011
179 FACIAL BONES FRACTURE 4 0.0011
180 BEHAVIOUR DISORDER 6 0.0011
181 IMMUNE-MEDIATED MYOSITIS 3 0.0011
182 BLOOD UREA INCREASED 18 0.0011
183 HEPATIC FUNCTION ABNORMAL 40 0.0011
184 SEDATION 28 0.0011
185 HYPOTHYROIDISM 34 0.0011
186 CHOLECYSTITIS ACUTE 6 0.0011
187 HYPERTHERMIA 8 0.0010
188 ILEUS 13 0.0010
189 COMA SCALE ABNORMAL 3 0.0010
190 VASCULITIS 12 0.0010
191 PARKINSONISM 10 0.0010
192 THINKING ABNORMAL 19 0.0010
193 ATAXIA 12 0.0010
194 HYPOGLYCAEMIA 49 0.0010
195 DELIRIUM 35 0.0010
196 MULTIPLE DRUG OVERDOSE 5 0.0010
197 FEELING COLD 28 0.0010
198 EXPOSURE VIA BREAST MILK 4 0.0010
199 RHABDOMYOLYSIS 41 0.0010
200 DYSARTHRIA 37 0.0010
201 SELF-MEDICATION 4 0.0010
202 INTERVERTEBRAL DISC DEGENERATION 9 0.0010
203 BENIGN PROSTATIC HYPERPLASIA 5 0.0010
204 DRUG INTERACTION 152 0.0010
205 ELECTROENCEPHALOGRAM ABNORMAL 3 0.0009
206 MENTAL IMPAIRMENT 23 0.0009
207 BLOOD PRESSURE DIASTOLIC DECREASED 7 0.0009
208 GAMMA-GLUTAMYLTRANSFERASE INCREASED 21 0.0009
209 LOWER GASTROINTESTINAL HAEMORRHAGE 7 0.0009
210 POLYMYALGIA RHEUMATICA 3 0.0009
211 CEREBRAL INFARCTION 23 0.0009
212 AORTIC VALVE INCOMPETENCE 4 0.0009
213 INTERVERTEBRAL DISC DISORDER 4 0.0009
214 COMPRESSION FRACTURE 5 0.0009
215 GINGIVITIS 5 0.0009
216 DISSEMINATED INTRAVASCULAR COAGULATION 13 0.0009
217 VITAMIN D DEFICIENCY 9 0.0009
218 BIPOLAR DISORDER 10 0.0009
219 NORMAL NEWBORN 5 0.0009
220 PULMONARY CONGESTION 12 0.0009
221 SUBDURAL HAEMATOMA 13 0.0009
222 BLOOD SODIUM DECREASED 17 0.0009
223 HALLUCINATION, VISUAL 19 0.0009
224 PLANTAR FASCIITIS 3 0.0009
225 POSTOPERATIVE WOUND INFECTION 6 0.0009
226 STATUS EPILEPTICUS 10 0.0009
227 ULCER 14 0.0009
228 IMPAIRED DRIVING ABILITY 10 0.0009
229 PANIC ATTACK 32 0.0009
230 BRONCHOPNEUMONIA 3 0.0009
231 ECCHYMOSIS 6 0.0009
232 LOSS OF CONSCIOUSNESS 112 0.0009
233 LUMBAR VERTEBRAL FRACTURE 4 0.0009
234 APLASIA PURE RED CELL 3 0.0009
235 SENSORY LOSS 7 0.0009
236 CERVICAL VERTEBRAL FRACTURE 3 0.0009
237 BLOOD CREATININE ABNORMAL 3 0.0009
238 ORTHOSTATIC HYPOTENSION 15 0.0009
239 ANOREXIA 11 0.0009
240 HANGOVER 3 0.0009
241 EMBOLIC STROKE 3 0.0009
242 ENERGY INCREASED 5 0.0008
243 HAND FRACTURE 6 0.0008
244 SPINAL COMPRESSION FRACTURE 7 0.0008
245 OVERDOSE 182 0.0008
246 MYOCLONUS 10 0.0008
247 FAECAL INCONTINENCE 4 0.0008
248 AFFECT LABILITY 8 0.0008
249 SCLERODERMA 3 0.0008
250 SCHIZOPHRENIA 10 0.0008
251 COGNITIVE DISORDER 38 0.0008
252 PANCREATIC DISORDER 4 0.0008
253 IMPAIRED GASTRIC EMPTYING 11 0.0008
254 INTERSTITIAL LUNG DISEASE 39 0.0008
255 HYPERAMMONAEMIA 4 0.0008
256 RESPIRATORY ARREST 22 0.0008
257 HEPATIC NECROSIS 3 0.0008
258 MULTIPLE INJURIES 5 0.0008
259 ECONOMIC PROBLEM 12 0.0008
260 DRUG TOLERANCE 4 0.0008
261 CHRONIC KIDNEY DISEASE 60 0.0008
262 DYSLIPIDAEMIA 4 0.0008
263 CONJUNCTIVAL HAEMORRHAGE 3 0.0008
264 GASTRIC INFECTION 3 0.0008
265 HYPOPHAGIA 20 0.0008
266 OESOPHAGEAL ULCER 3 0.0008
267 OESOPHAGEAL DISORDER 3 0.0008
268 ASPARTATE AMINOTRANSFERASE INCREASED 41 0.0008
269 POLYDIPSIA 3 0.0008
270 POLYARTHRITIS 4 0.0008
271 HEAD INJURY 24 0.0008
272 MENTAL DISORDER 33 0.0008
273 ABNORMAL BEHAVIOUR 30 0.0008
274 CANDIDIASIS 3 0.0007
275 SENSORY DISTURBANCE 12 0.0007
276 ATRIOVENTRICULAR BLOCK COMPLETE 5 0.0007
277 BREAST MASS 5 0.0007
278 NOCTURIA 9 0.0007
279 SUBSTANCE ABUSE 6 0.0007
280 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 3 0.0007
281 DRUG TOXICITY 10 0.0007
282 DRUG ERUPTION 13 0.0007
283 HYPERURICAEMIA 3 0.0007
284 VENTRICULAR TACHYCARDIA 12 0.0007
285 PHARYNGITIS 9 0.0007
286 GASTRIC ULCER HAEMORRHAGE 4 0.0007
287 VENTRICULAR FIBRILLATION 8 0.0007
288 ALANINE AMINOTRANSFERASE INCREASED 44 0.0007
289 INTERMENSTRUAL BLEEDING 4 0.0007
290 SELF-INJURIOUS IDEATION 3 0.0007
291 RIGHT VENTRICULAR FAILURE 5 0.0007
292 END STAGE RENAL DISEASE 13 0.0007
293 FEAR 19 0.0007
294 LUNG NEOPLASM 3 0.0007
295 CARDIAC VALVE DISEASE 4 0.0007
296 CONTRAINDICATED PRODUCT ADMINISTERED 21 0.0007
297 BLOOD URIC ACID INCREASED 4 0.0007
298 HYPERTHYROIDISM 10 0.0007
299 HYPERVENTILATION 4 0.0007
300 SUICIDAL IDEATION 63 0.0007
301 TOOTH ABSCESS 7 0.0007
302 MOTOR DYSFUNCTION 7 0.0007
303 URINE OUTPUT DECREASED 6 0.0007
304 ONYCHOMYCOSIS 3 0.0007
305 GINGIVAL SWELLING 3 0.0007
306 LIGAMENT RUPTURE 3 0.0007
307 WHITE BLOOD CELL COUNT INCREASED 26 0.0007
308 CATHETERISATION CARDIAC 3 0.0007
309 GLAUCOMA 13 0.0007
310 RHINITIS ALLERGIC 3 0.0007
311 HYPERLIPIDAEMIA 8 0.0007
312 PROTHROMBIN TIME PROLONGED 4 0.0007
313 JOINT DISLOCATION 7 0.0007
314 CONFUSIONAL STATE 107 0.0007
315 DRUG EFFECT DELAYED 3 0.0007
316 HAEMOGLOBIN INCREASED 3 0.0007
317 AORTIC ANEURYSM 5 0.0007
318 TENSION 4 0.0007
319 DYSPAREUNIA 3 0.0007
320 PROCEDURAL COMPLICATION 5 0.0007
321 MENISCUS INJURY 4 0.0006
322 RENAL FAILURE CHRONIC 5 0.0006
323 IRON DEFICIENCY ANAEMIA 6 0.0006
324 CARDIO-RESPIRATORY ARREST 27 0.0006
325 SOMNOLENCE 130 0.0006
326 ROAD TRAFFIC ACCIDENT 27 0.0006
327 CHOLANGITIS 4 0.0006
328 ROSACEA 3 0.0006
329 FEELING OF DESPAIR 3 0.0006
330 ARTERIAL OCCLUSIVE DISEASE 5 0.0006
331 INFUSION SITE SWELLING 4 0.0006
332 TOOTH FRACTURE 7 0.0006
333 TRICUSPID VALVE INCOMPETENCE 5 0.0006
334 APHASIA 19 0.0006
335 METABOLIC ACIDOSIS 20 0.0006
336 INTENTIONAL DRUG MISUSE 13 0.0006
337 POOR QUALITY DRUG ADMINISTERED 4 0.0006
338 INTENTIONAL PRODUCT MISUSE 54 0.0006
339 ANGINA UNSTABLE 4 0.0006
340 DECUBITUS ULCER 5 0.0006
341 BLOOD CREATININE INCREASED 40 0.0006
342 DISORIENTATION 24 0.0006
343 DRUG LEVEL INCREASED 10 0.0006
344 FLUID INTAKE REDUCED 3 0.0006
345 POST-TRAUMATIC STRESS DISORDER 4 0.0006
346 RENAL IMPAIRMENT 50 0.0006
347 DRUG USE DISORDER 5 0.0006
348 DYSPHORIA 3 0.0006
349 SPEECH DISORDER 31 0.0006
350 SUBARACHNOID HAEMORRHAGE 6 0.0006
351 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 4 0.0006
352 LIVER DISORDER 26 0.0006
353 HYPONATRAEMIA 33 0.0006
354 MUSCLE RIGIDITY 7 0.0006
355 INITIAL INSOMNIA 6 0.0006
356 CHOLELITHIASIS 19 0.0006
357 HAIR GROWTH ABNORMAL 4 0.0006
358 RENAL INJURY 17 0.0006
359 CARDIOMEGALY 7 0.0006
360 OSTEOARTHRITIS 24 0.0006
361 NYSTAGMUS 3 0.0006
362 DISTURBANCE IN ATTENTION 30 0.0006
363 CHEILITIS 3 0.0006
364 ERYTHEMA OF EYELID 3 0.0006
365 MUSCLE ATROPHY 7 0.0006
366 EXOSTOSIS 5 0.0005
367 MANIA 9 0.0005
368 RESTLESSNESS 20 0.0005
369 MYDRIASIS 7 0.0005
370 ROTATOR CUFF SYNDROME 7 0.0005
371 PHOTOSENSITIVITY REACTION 9 0.0005
372 PNEUMONIA BACTERIAL 5 0.0005
373 HYPERKALAEMIA 19 0.0005
374 CARDIOMYOPATHY 8 0.0005
375 PULMONARY ALVEOLAR HAEMORRHAGE 3 0.0005
376 FIBROMYALGIA 13 0.0005
377 PAROSMIA 4 0.0005
378 TOXIC EPIDERMAL NECROLYSIS 8 0.0005
379 GASTRIC ULCER 10 0.0005
380 DERMATITIS CONTACT 6 0.0005
381 DERMATITIS 11 0.0005
382 NEUROLOGICAL SYMPTOM 3 0.0005
383 ENTEROCOLITIS 3 0.0005
384 AGITATION 38 0.0005
385 DYSKINESIA 21 0.0005
386 APNOEA 4 0.0005
387 AKATHISIA 7 0.0005
388 ACUTE HEPATIC FAILURE 7 0.0005
389 FEELING OF BODY TEMPERATURE CHANGE 3 0.0005
390 BLOOD PRESSURE DECREASED 34 0.0005
391 PULMONARY HAEMORRHAGE 4 0.0005
392 PRODUCT ADMINISTRATION INTERRUPTED 4 0.0005
393 BRADYCARDIA 27 0.0005
394 AFFECTIVE DISORDER 4 0.0005
395 DECREASED INTEREST 3 0.0005
396 GLUCOSE TOLERANCE IMPAIRED 3 0.0005
397 ARRHYTHMIA 24 0.0005
398 DRUG SCREEN POSITIVE 4 0.0005
399 ACTIVITIES OF DAILY LIVING IMPAIRED 10 0.0005
400 PRODUCT PRESCRIBING ISSUE 11 0.0005
401 THIRST 9 0.0005
402 CHOLECYSTITIS 6 0.0005
403 OBESITY 8 0.0005
404 ATRIAL FLUTTER 4 0.0005
405 WRIST FRACTURE 6 0.0005
406 GASTROENTERITIS VIRAL 9 0.0005
407 OBSESSIVE-COMPULSIVE DISORDER 4 0.0005
408 OSTEOMYELITIS 9 0.0005
409 INJECTION SITE VESICLES 3 0.0005
410 INSOMNIA 132 0.0005
411 NEURALGIA 12 0.0005
412 AMNESIA 32 0.0005
413 DEPRESSED MOOD 26 0.0005
414 DRUG LEVEL DECREASED 5 0.0005
415 INTERNATIONAL NORMALISED RATIO INCREASED 14 0.0005
416 RESPIRATORY DEPRESSION 6 0.0005
417 DRUG ABUSER 3 0.0005
418 DEPRESSION 111 0.0005
419 GENERALISED TONIC-CLONIC SEIZURE 8 0.0005
420 RENAL FAILURE 64 0.0005
421 BLOOD BILIRUBIN INCREASED 13 0.0005
422 EYE DISCHARGE 5 0.0005
423 DRUG WITHDRAWAL SYNDROME NEONATAL 7 0.0005
424 RENAL FAILURE ACUTE 20 0.0005
425 PULMONARY MASS 7 0.0005
426 COLON CANCER 7 0.0005
427 PULMONARY OEDEMA 21 0.0005
428 BONE LOSS 7 0.0005
429 MUSCULOSKELETAL DISCOMFORT 8 0.0005
430 CARDIAC FLUTTER 3 0.0005
431 ANXIETY 132 0.0005
432 MUSCLE STRAIN 4 0.0005
433 CARDIAC MURMUR 4 0.0005
434 REFUSAL OF TREATMENT BY PATIENT 3 0.0005
435 GASTRITIS 12 0.0005
436 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 4 0.0005
437 TENDONITIS 7 0.0005
438 DENTAL CARIES 5 0.0005
439 HEAD DISCOMFORT 8 0.0005
440 BLOOD CHOLESTEROL INCREASED 21 0.0005
441 STEVENS-JOHNSON SYNDROME 10 0.0004
442 HYPERTENSIVE CRISIS 5 0.0004
443 CHOLECYSTITIS CHRONIC 3 0.0004
444 DEEP VEIN THROMBOSIS 29 0.0004
445 GASTROINTESTINAL INFECTION 4 0.0004
446 MYOSITIS 4 0.0004
447 THERAPEUTIC RESPONSE UNEXPECTED 20 0.0004
448 METASTASES TO LYMPH NODES 3 0.0004
449 CHROMATURIA 10 0.0004
450 LEUKOCYTOSIS 8 0.0004
451 MITRAL VALVE INCOMPETENCE 5 0.0004
452 PELVIC PAIN 8 0.0004
453 C-REACTIVE PROTEIN INCREASED 16 0.0004
454 AGGRESSION 22 0.0004
455 HYPERGLYCAEMIA 16 0.0004
456 BLOOD TESTOSTERONE DECREASED 3 0.0004
457 EYE MOVEMENT DISORDER 3 0.0004
458 PERIPHERAL COLDNESS 6 0.0004
459 DRUG DEPENDENCE 70 0.0004
460 JOINT EFFUSION 3 0.0004
461 BLOOD THYROID STIMULATING HORMONE INCREASED 4 0.0004
462 ENCEPHALITIS 3 0.0004
463 LARGE INTESTINE POLYP 3 0.0004
464 FALL 144 0.0004
465 BLOOD POTASSIUM DECREASED 13 0.0004
466 HYPERTRANSAMINASAEMIA 3 0.0004
467 HEPATIC FAILURE 13 0.0004
468 BLOOD POTASSIUM INCREASED 7 0.0004
469 BACK DISORDER 7 0.0004
470 ELECTROLYTE IMBALANCE 5 0.0004
471 EXTRASYSTOLES 3 0.0004
472 CAESAREAN SECTION 5 0.0004
473 PAPULE 3 0.0004
474 LACERATION 4 0.0004
475 ARTERIOSCLEROSIS 4 0.0004
476 ACUTE KIDNEY INJURY 65 0.0004
477 HAEMATOMA 11 0.0004
478 SINUS TACHYCARDIA 6 0.0004
479 SPINAL DISORDER 4 0.0004
480 DIVERTICULUM 3 0.0004
481 RETINAL HAEMORRHAGE 3 0.0004
482 PARALYSIS 6 0.0004
483 ANHEDONIA 11 0.0004
484 ACUTE RESPIRATORY FAILURE 8 0.0004
485 SINUS BRADYCARDIA 4 0.0004
486 BURSITIS 5 0.0004
487 INTERVERTEBRAL DISC PROTRUSION 9 0.0004
488 HYPOKALAEMIA 19 0.0004
489 APATHY 6 0.0004
490 MOUTH HAEMORRHAGE 3 0.0004
491 JAUNDICE 11 0.0004
492 ASCITES 12 0.0004
493 RENAL TUBULAR NECROSIS 4 0.0004
494 HYPOPHOSPHATAEMIA 3 0.0004
495 HYPERCALCAEMIA 5 0.0004
496 ARTHROPOD BITE 3 0.0004
497 LIGAMENT SPRAIN 4 0.0004
498 OSTEONECROSIS OF JAW 10 0.0004
499 GLOSSODYNIA 9 0.0004
500 NERVOUSNESS 21 0.0004
501 EPISTAXIS 30 0.0004
502 OVARIAN CYST 4 0.0004
503 SALIVARY HYPERSECRETION 4 0.0004
504 SYNCOPE 40 0.0004
505 RESPIRATORY DISTRESS 11 0.0004
506 HYPOXIA 14 0.0004
507 PEMPHIGOID 3 0.0004
508 CELLULITIS 20 0.0004
509 BLOOD TRIGLYCERIDES INCREASED 7 0.0004
510 MENTAL STATUS CHANGES 11 0.0004
511 STOMATITIS 24 0.0004
512 HAEMOPTYSIS 11 0.0004
513 DISCOMFORT 24 0.0004
514 BODY TEMPERATURE INCREASED 8 0.0004
515 SHOCK 9 0.0004
516 CEREBRAL HAEMORRHAGE 14 0.0004
517 THYROID DISORDER 6 0.0004
518 RIB FRACTURE 8 0.0004
519 FOOD ALLERGY 3 0.0004
520 ANKLE FRACTURE 6 0.0004
521 APHTHOUS ULCER 3 0.0004
522 HIATUS HERNIA 5 0.0004
523 HYPERBILIRUBINAEMIA 4 0.0004
524 TRANSIENT ISCHAEMIC ATTACK 13 0.0004
525 CRYING 14 0.0004
526 GASTROOESOPHAGEAL REFLUX DISEASE 31 0.0004
527 PHARMACEUTICAL PRODUCT COMPLAINT 10 0.0004
528 ANGINA PECTORIS 11 0.0004
529 TENDERNESS 4 0.0004
530 MULTIPLE ALLERGIES 3 0.0004
531 IRRITABILITY 23 0.0004
532 DEAFNESS 10 0.0004
533 ELECTROCARDIOGRAM ABNORMAL 3 0.0004
534 DIABETES MELLITUS 29 0.0004
535 BEDRIDDEN 5 0.0004
536 BLOOD ALBUMIN DECREASED 3 0.0004
537 HALLUCINATION, AUDITORY 6 0.0004
538 GINGIVAL PAIN 3 0.0004
539 HEPATIC STEATOSIS 7 0.0004
540 EAR INFECTION 10 0.0004
541 CARDIAC ARREST 31 0.0004
542 ACUTE MYOCARDIAL INFARCTION 11 0.0004
543 TACHYCARDIA 33 0.0004
544 TINNITUS 17 0.0004
545 FRACTURE 7 0.0004
546 ARTHRITIS 29 0.0004
547 LIMB INJURY 10 0.0004
548 PALLOR 10 0.0004
549 FEELING JITTERY 7 0.0004
550 INCREASED APPETITE 7 0.0004
551 GINGIVAL BLEEDING 5 0.0004
552 METASTASES TO BONE 6 0.0004
553 CORONARY ARTERY OCCLUSION 5 0.0004
554 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 19 0.0004
555 CENTRAL NERVOUS SYSTEM LESION 5 0.0004
556 GASTROINTESTINAL PAIN 4 0.0004
557 EMBOLISM 3 0.0004
558 DIVERTICULITIS 10 0.0004
559 COAGULOPATHY 6 0.0004
560 EOSINOPHIL COUNT INCREASED 3 0.0004
561 DEHYDRATION 48 0.0004
562 OBSTRUCTIVE AIRWAYS DISORDER 4 0.0004
563 BALANCE DISORDER 31 0.0004
564 APHONIA 5 0.0004
565 MALNUTRITION 4 0.0004
566 CARPAL TUNNEL SYNDROME 5 0.0004
567 RESPIRATORY FAILURE 26 0.0004
568 PANCREATITIS ACUTE 8 0.0004
569 MALAISE 155 0.0004
570 HAEMATOCRIT DECREASED 7 0.0004
571 DRUG EFFECT DECREASED 19 0.0004
572 SCAB 4 0.0004
573 ERECTILE DYSFUNCTION 9 0.0004
574 CONVULSION 20 0.0003
575 DECREASED APPETITE 81 0.0003
576 PSYCHOLOGICAL TRAUMA 3 0.0003
577 TREATMENT NONCOMPLIANCE 19 0.0003
578 HYSTERECTOMY 3 0.0003
579 PRODUCT ADMINISTRATION ERROR 7 0.0003
580 INTESTINAL OBSTRUCTION 13 0.0003
581 EYELID OEDEMA 4 0.0003
582 LIVER FUNCTION TEST ABNORMAL 10 0.0003
583 GASTROENTERITIS 5 0.0003
584 SPLENOMEGALY 4 0.0003
585 INJURY 24 0.0003
586 SPINAL PAIN 4 0.0003
587 METASTASES TO LIVER 6 0.0003
588 HAEMOGLOBIN DECREASED 35 0.0003
589 SLEEP DISORDER 24 0.0003
590 ACUTE RESPIRATORY DISTRESS SYNDROME 6 0.0003
591 DIABETES MELLITUS INADEQUATE CONTROL 6 0.0003
592 PLATELET COUNT DECREASED 36 0.0003
593 BRONCHITIS 25 0.0003
594 DYSPHAGIA 32 0.0003
595 CARDIAC FAILURE 27 0.0003
596 MACULAR DEGENERATION 4 0.0003
597 WITHDRAWAL SYNDROME 14 0.0003
598 HYPOAESTHESIA ORAL 5 0.0003
599 RESTLESS LEGS SYNDROME 6 0.0003
600 GAIT DISTURBANCE 63 0.0003
601 HYPOTENSION 66 0.0003
602 VERTIGO 20 0.0003
603 IRRITABLE BOWEL SYNDROME 7 0.0003
604 TREMOR 54 0.0003
605 UPPER RESPIRATORY TRACT INFECTION 15 0.0003
606 MEDICATION ERROR 18 0.0003
607 EJECTION FRACTION DECREASED 5 0.0003
608 ERYTHEMA MULTIFORME 3 0.0003
609 HAIR COLOUR CHANGES 4 0.0003
610 MIDDLE INSOMNIA 6 0.0003
611 OXYGEN SATURATION DECREASED 18 0.0003
612 PHOTOPHOBIA 6 0.0003
613 HALLUCINATION 24 0.0003
614 NIGHTMARE 11 0.0003
615 HYPOCALCAEMIA 6 0.0003
616 MUSCULAR WEAKNESS 36 0.0003
617 BRAIN OEDEMA 4 0.0003
618 OSTEOPOROSIS 13 0.0003
619 TRANSAMINASES INCREASED 7 0.0003
620 CYSTITIS 10 0.0003
621 SCIATICA 5 0.0003
622 DRUG PRESCRIBING ERROR 6 0.0003
623 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 15 0.0003
624 DRUG RESISTANCE 8 0.0003
625 ASTHENIA 117 0.0003
626 INFUSION SITE PAIN 4 0.0003
627 METASTASES TO CENTRAL NERVOUS SYSTEM 4 0.0003
628 DYSSTASIA 9 0.0003
629 ATRIAL FIBRILLATION 30 0.0003
630 DIPLOPIA 8 0.0003
631 BLOOD PRESSURE SYSTOLIC INCREASED 6 0.0003
632 BODY TEMPERATURE DECREASED 3 0.0003
633 OEDEMA PERIPHERAL 37 0.0003
634 DISABILITY 6 0.0003
635 PRESCRIBED UNDERDOSE 6 0.0003
636 URINARY RETENTION 10 0.0003
637 PNEUMOCYSTIS JIROVECII PNEUMONIA 3 0.0003
638 PYREXIA 103 0.0003
639 HYPOTHERMIA 3 0.0003
640 FEEDING DISORDER 6 0.0003
641 OEDEMA 16 0.0003
642 SLUGGISHNESS 3 0.0003
643 ANAEMIA 56 0.0003
644 MIGRAINE 28 0.0003
645 EUPHORIC MOOD 3 0.0003
646 PALPITATIONS 34 0.0003
647 ABNORMAL DREAMS 8 0.0003
648 PERITONITIS 6 0.0003
649 MULTI-ORGAN FAILURE 5 0.0003
650 BLOOD PRESSURE INCREASED 44 0.0003
651 BONE DENSITY DECREASED 9 0.0003
652 HYPERHIDROSIS 37 0.0003
653 HUNGER 4 0.0003
654 COORDINATION ABNORMAL 4 0.0003
655 CARDIAC FAILURE CONGESTIVE 23 0.0003
656 MASS 4 0.0003
657 FOLLICULITIS 3 0.0003
658 HEART RATE DECREASED 10 0.0003
659 PNEUMONIA 92 0.0003
660 TARDIVE DYSKINESIA 8 0.0003
661 HYPERTENSION 60 0.0003
662 LYMPHOPENIA 4 0.0003
663 DIALYSIS 4 0.0003
664 JOINT INJURY 6 0.0003
665 BODY HEIGHT DECREASED 3 0.0003
666 BRONCHOSPASM 4 0.0003
667 RED BLOOD CELL COUNT DECREASED 8 0.0003
668 HYPERSOMNIA 8 0.0003
669 GLYCOSYLATED HAEMOGLOBIN INCREASED 7 0.0003
670 PARAESTHESIA ORAL 4 0.0003
671 PHARYNGITIS STREPTOCOCCAL 3 0.0003
672 WRONG TECHNIQUE IN DRUG USAGE PROCESS 10 0.0003
673 CONSTIPATION 60 0.0003
674 ACCIDENTAL OVERDOSE 10 0.0003
675 NEUROPATHY PERIPHERAL 26 0.0003
676 DYSURIA 10 0.0003
677 FEELING ABNORMAL 65 0.0003
678 DIZZINESS 135 0.0003
679 FOOT DEFORMITY 3 0.0003
680 NEUTROPHIL COUNT DECREASED 11 0.0003
681 TOOTH DISORDER 6 0.0003
682 TUBULOINTERSTITIAL NEPHRITIS 5 0.0003
683 EYE INFECTION 3 0.0003
684 UNEVALUABLE EVENT 20 0.0003
685 POLLAKIURIA 11 0.0003
686 WEIGHT INCREASED 59 0.0003
687 BLOOD URINE PRESENT 5 0.0003
688 GASTROINTESTINAL HAEMORRHAGE 22 0.0003
689 CHOLECYSTECTOMY 3 0.0003
690 DRUG WITHDRAWAL SYNDROME 23 0.0003
691 EPILEPSY 8 0.0003
692 NEPHROLITHIASIS 12 0.0003
693 PULMONARY FIBROSIS 5 0.0003
694 LOWER LIMB FRACTURE 5 0.0003
695 CONDITION AGGRAVATED 79 0.0003
696 LYMPHOMA 4 0.0003
697 HERNIA 5 0.0003
698 MADAROSIS 3 0.0003
699 PRESCRIBED OVERDOSE 5 0.0003
700 URINARY TRACT INFECTION 44 0.0003
701 SURGERY 15 0.0003
702 DRUG-INDUCED LIVER INJURY 8 0.0003
703 CYANOSIS 4 0.0003
704 COVID-19 PNEUMONIA 3 0.0003
705 PROCEDURAL PAIN 7 0.0003
706 PRODUCT PHYSICAL ISSUE 5 0.0002
707 ABDOMINAL PAIN UPPER 51 0.0002
708 ADRENAL INSUFFICIENCY 3 0.0002
709 PAIN IN JAW 7 0.0002
710 PRESYNCOPE 6 0.0002
711 NO THERAPEUTIC RESPONSE 3 0.0002
712 GLOMERULAR FILTRATION RATE DECREASED 3 0.0002
713 HERPES ZOSTER 14 0.0002
714 LETHARGY 14 0.0002
715 ABASIA 6 0.0002
716 FEBRILE NEUTROPENIA 16 0.0002
717 SKIN DISORDER 8 0.0002
718 SKIN DISCOLOURATION 11 0.0002
719 DYSPNOEA EXERTIONAL 9 0.0002
720 HOT FLUSH 18 0.0002
721 CHEST PAIN 44 0.0002
722 PSYCHOTIC DISORDER 7 0.0002
723 HAEMATEMESIS 6 0.0002
724 ANGER 8 0.0002
725 SINUSITIS 24 0.0002
726 IMPAIRED WORK ABILITY 5 0.0002
727 MEMORY IMPAIRMENT 32 0.0002
728 UNRESPONSIVE TO STIMULI 6 0.0002
729 BACK PAIN 54 0.0002
730 HEART RATE INCREASED 23 0.0002
731 FAECES DISCOLOURED 5 0.0002
732 PLEURAL EFFUSION 14 0.0002
733 JOINT STIFFNESS 6 0.0002
734 MUSCULOSKELETAL STIFFNESS 20 0.0002
735 IMMUNE SYSTEM DISORDER 3 0.0002
736 MELAENA 5 0.0002
737 LYMPHOCYTE COUNT DECREASED 4 0.0002
738 CHEST DISCOMFORT 23 0.0002
739 LUNG DISORDER 11 0.0002
740 NERVOUS SYSTEM DISORDER 7 0.0002
741 HAIR TEXTURE ABNORMAL 3 0.0002
742 GALLBLADDER DISORDER 4 0.0002
743 GASTROINTESTINAL DISORDER 20 0.0002
744 GOUT 4 0.0002
745 SINUS CONGESTION 3 0.0002
746 BONE PAIN 13 0.0002
747 TOOTHACHE 4 0.0002
748 ABDOMINAL DISTENSION 23 0.0002
749 BONE DISORDER 4 0.0002
750 LUNG NEOPLASM MALIGNANT 9 0.0002
751 MULTIPLE SCLEROSIS RELAPSE 15 0.0002
752 DRUG INEFFECTIVE 288 0.0002
753 PROSTATIC SPECIFIC ANTIGEN INCREASED 3 0.0002
754 HIP FRACTURE 7 0.0002
755 NIGHT SWEATS 7 0.0002
756 INTENTIONAL PRODUCT USE ISSUE 19 0.0002
757 ORAL DISCOMFORT 3 0.0002
758 CONJUNCTIVITIS 4 0.0002
759 DYSPNOEA 122 0.0002
760 WEIGHT DECREASED 60 0.0002
761 WOUND 6 0.0002
762 BACTERIAL INFECTION 4 0.0002
763 THERAPY CESSATION 11 0.0002
764 INFLAMMATION 11 0.0002
765 BLINDNESS UNILATERAL 3 0.0002
766 FATIGUE 165 0.0002
767 HEPATOCELLULAR INJURY 3 0.0002
768 FOOT FRACTURE 4 0.0002
769 CHOLESTASIS 4 0.0002
770 POST PROCEDURAL COMPLICATION 4 0.0002
771 DIABETIC KETOACIDOSIS 5 0.0002
772 SEPTIC SHOCK 9 0.0002
773 ERUCTATION 4 0.0002
774 VOMITING 97 0.0002
775 DYSTONIA 4 0.0002
776 NAUSEA 163 0.0002
777 EAR PAIN 4 0.0002
778 HEPATIC ENZYME INCREASED 14 0.0002
779 DYSPHONIA 12 0.0002
780 ENCEPHALOPATHY 5 0.0002
781 PAIN 125 0.0002
782 FULL BLOOD COUNT DECREASED 4 0.0002
783 CORONARY ARTERY DISEASE 6 0.0002
784 ARTHROPATHY 11 0.0002
785 OSTEOPENIA 3 0.0002
786 GASTRIC CANCER 5 0.0002
787 CONTUSION 19 0.0002
788 NECK PAIN 11 0.0002
789 CHILLS 23 0.0002
790 BLISTER 11 0.0002
791 HEPATITIS 5 0.0002
792 NASOPHARYNGITIS 36 0.0002
793 OROPHARYNGEAL PAIN 18 0.0002
794 MUSCULOSKELETAL CHEST PAIN 3 0.0002
795 HYPOAESTHESIA 29 0.0002
796 LUNG INFECTION 3 0.0002
797 CARDIAC DISORDER 18 0.0002
798 DIARRHOEA 124 0.0002
799 ABDOMINAL DISCOMFORT 32 0.0002
800 PAIN IN EXTREMITY 56 0.0002
801 HEADACHE 119 0.0002
802 PULMONARY EMBOLISM 18 0.0002
803 RESPIRATORY TRACT CONGESTION 3 0.0002
804 PRODUCTIVE COUGH 9 0.0002
805 MULTIPLE SCLEROSIS 9 0.0002
806 EATING DISORDER 4 0.0002
807 RETCHING 4 0.0002
808 POOR QUALITY SLEEP 4 0.0002
809 ASTHMA 21 0.0002
810 DRY MOUTH 15 0.0002
811 THROAT TIGHTNESS 5 0.0002
812 ABDOMINAL PAIN 43 0.0002
813 COLITIS 7 0.0002
814 MULTIPLE FRACTURES 3 0.0002
815 SKIN LESION 5 0.0002
816 HAEMORRHAGE 19 0.0002
817 VISUAL ACUITY REDUCED 6 0.0002
818 FUNGAL INFECTION 6 0.0002
819 PANCYTOPENIA 10 0.0002
820 DEMENTIA 5 0.0002
821 TYPE 2 DIABETES MELLITUS 6 0.0002
822 HEMIPARESIS 3 0.0002
823 MULTIPLE ORGAN DYSFUNCTION SYNDROME 5 0.0002
824 CIRCULATORY COLLAPSE 3 0.0002
825 METRORRHAGIA 3 0.0002
826 INTENTIONAL DOSE OMISSION 5 0.0002
827 WHITE BLOOD CELL COUNT DECREASED 19 0.0002
828 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 3 0.0002
829 DYSGEUSIA 13 0.0002
830 MUSCLE TWITCHING 4 0.0002
831 ECZEMA 9 0.0002
832 RENAL DISORDER 8 0.0002
833 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 4 0.0002
834 THROMBOCYTOPENIA 19 0.0002
835 NEUTROPENIA 23 0.0002
836 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 12 0.0002
837 ISCHAEMIC STROKE 3 0.0002
838 RESPIRATORY DISORDER 5 0.0002
839 BLOOD PRESSURE FLUCTUATION 4 0.0002
840 MALIGNANT NEOPLASM PROGRESSION 17 0.0002
841 INFECTION 24 0.0002
842 DRUG EFFECT INCOMPLETE 6 0.0002
843 MUSCLE SPASMS 30 0.0002
844 FEELING HOT 10 0.0002
845 DRUG ADMINISTRATION ERROR 5 0.0002
846 BLOOD GLUCOSE ABNORMAL 3 0.0002
847 EMOTIONAL DISORDER 5 0.0002
848 INFLUENZA 18 0.0002
849 EXTRAPYRAMIDAL DISORDER 4 0.0002
850 AGEUSIA 4 0.0002
851 SWOLLEN TONGUE 5 0.0002
852 LEUKOPENIA 8 0.0002
853 HEPATIC CIRRHOSIS 3 0.0002
854 FLUSHING 16 0.0002
855 EMOTIONAL DISTRESS 19 0.0002
856 BURNING SENSATION 11 0.0002
857 MOOD SWINGS 5 0.0002
858 MOVEMENT DISORDER 5 0.0002
859 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 4 0.0002
860 ANAPHYLACTIC SHOCK 4 0.0002
861 SKIN ULCER 4 0.0002
862 RASH GENERALISED 4 0.0002
863 VISION BLURRED 21 0.0002
864 MUCOSAL INFLAMMATION 4 0.0002
865 MENORRHAGIA 3 0.0002
866 MUSCULOSKELETAL PAIN 8 0.0002
867 PARAESTHESIA 24 0.0002
868 SEPSIS 17 0.0002
869 IMPAIRED HEALING 5 0.0002
870 OSTEONECROSIS 5 0.0002
871 SINUS DISORDER 3 0.0002
872 PANCREATITIS 8 0.0002
873 CATARACT 9 0.0002
874 THERAPEUTIC RESPONSE SHORTENED 5 0.0002
875 VIRAL INFECTION 5 0.0002
876 LIP SWELLING 5 0.0001
877 THROMBOSIS 12 0.0001
878 MYOCARDIAL INFARCTION 26 0.0001
879 EYE PRURITUS 5 0.0001
880 BONE MARROW FAILURE 3 0.0001
881 PRODUCT QUALITY ISSUE 20 0.0001
882 MYALGIA 25 0.0001
883 PNEUMONITIS 4 0.0001
884 HAEMATURIA 5 0.0001
885 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 8 0.0001
886 PSORIASIS 19 0.0001
887 ARTHRALGIA 60 0.0001
888 COVID-19 25 0.0001
889 KNEE ARTHROPLASTY 3 0.0001
890 MOUTH ULCERATION 3 0.0001
891 INCORRECT DRUG ADMINISTRATION DURATION 4 0.0001
892 PRODUCT USE IN UNAPPROVED INDICATION 35 0.0001
893 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 10 0.0001
894 RECTAL HAEMORRHAGE 6 0.0001
895 MOBILITY DECREASED 10 0.0001
896 PRODUCT SUBSTITUTION ISSUE 8 0.0001
897 SWELLING 13 0.0001
898 PRURITUS GENERALISED 3 0.0001
899 SEIZURE 16 0.0001
900 GENERAL PHYSICAL HEALTH DETERIORATION 16 0.0001
901 FLUID RETENTION 7 0.0001
902 NEEDLE ISSUE 4 0.0001
903 UNDERDOSE 10 0.0001
904 ILLNESS 14 0.0001
905 DEATH 117 0.0001
906 RASH PAPULAR 3 0.0001
907 SNEEZING 3 0.0001
908 INFLUENZA LIKE ILLNESS 11 0.0001
909 ALOPECIA 26 0.0001
910 APPLICATION SITE PRURITUS 3 0.0001
911 ILL-DEFINED DISORDER 8 0.0001
912 FEMUR FRACTURE 4 0.0001
913 VISUAL IMPAIRMENT 16 0.0001
914 HAEMATOCHEZIA 7 0.0001
915 DISEASE RECURRENCE 6 0.0001
916 PRODUCT PRESCRIBING ERROR 3 0.0001
917 EYE PAIN 7 0.0001
918 LOCALISED INFECTION 3 0.0001
919 CEREBROVASCULAR ACCIDENT 21 0.0001
920 RASH 54 0.0001
921 RHINORRHOEA 8 0.0001
922 EXTRA DOSE ADMINISTERED 5 0.0001
923 BLINDNESS 5 0.0001
924 INCORRECT DOSE ADMINISTERED 28 0.0001
925 PRURITUS 47 0.0001
926 EYE DISORDER 4 0.0001
927 EXPIRED PRODUCT ADMINISTERED 4 0.0001
928 GAIT INABILITY 4 0.0001
929 NASAL CONGESTION 7 0.0001
930 OFF LABEL USE 104 0.0001
931 SKIN EXFOLIATION 10 0.0001
932 PRODUCT COMPLAINT 3 0.0001
933 PRODUCT USE ISSUE 22 0.0001
934 GASTRIC DISORDER 4 0.0001
935 HYPOACUSIS 5 0.0001
936 RESPIRATORY TRACT INFECTION 3 0.0001
937 PRODUCT ADHESION ISSUE 4 0.0001
938 MOOD ALTERED 3 0.0001
939 DISEASE PROGRESSION 13 0.0001
940 DEPENDENCE 6 0.0001
941 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 22 0.0001
942 INJECTION SITE MASS 4 0.0001
943 URTICARIA 18 0.0001
944 ERYTHEMA 22 0.0001
945 FLATULENCE 6 0.0001
946 OCULAR HYPERAEMIA 5 0.0001
947 RASH ERYTHEMATOUS 5 0.0001
948 BLOOD GLUCOSE DECREASED 5 0.0001
949 COUGH 29 0.0001
950 LABORATORY TEST ABNORMAL 3 0.0001
951 LACRIMATION INCREASED 3 0.0001
952 THERAPEUTIC RESPONSE DECREASED 6 0.0001
953 GYNAECOMASTIA 3 0.0001
954 LIMB DISCOMFORT 3 0.0001
955 DRUG DOSE OMISSION 16 0.0001
956 PERIPHERAL SWELLING 14 0.0001
957 INJECTION SITE PRURITUS 6 0.0001
958 THERAPY NON-RESPONDER 4 0.0001
959 INJECTION SITE ERYTHEMA 11 0.0001
960 EYE IRRITATION 5 0.0001
961 FOETAL EXPOSURE DURING PREGNANCY 7 0.0001
962 LYMPHADENOPATHY 3 0.0001
963 HOSPITALISATION 13 0.0001
964 TREATMENT FAILURE 7 0.0001
965 WHEEZING 5 0.0001
966 JOINT SWELLING 10 0.0001
967 DRUG INTOLERANCE 8 0.0001
968 EYE SWELLING 3 0.0001
969 RHEUMATOID ARTHRITIS 9 0.0001
970 SWELLING FACE 5 0.0001
971 INFUSION RELATED REACTION 5 0.0001
972 HYPERSENSITIVITY 14 0.0001
973 INJECTION SITE BRUISING 6 0.0001
974 NEOPLASM MALIGNANT 5 0.0001
975 BLOOD GLUCOSE INCREASED 14 0.0001
976 RASH PRURITIC 4 0.0001
977 INJECTION SITE REACTION 5 0.0001
978 DRY SKIN 9 0.0001
979 COLITIS ULCERATIVE 3 0.0001
980 ADVERSE DRUG REACTION 6 0.0001
981 INJECTION SITE SWELLING 5 0.0001
982 ADVERSE EVENT 6 0.0001
983 PRODUCT DOSE OMISSION 4 0.0001
984 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 11 0.0001
985 DYSPEPSIA 6 0.0001
986 INJECTION SITE PAIN 18 0.0001
987 INJECTION SITE HAEMORRHAGE 4 0.0001
988 PRODUCT DOSE OMISSION ISSUE 14 0.0000
989 MATERNAL EXPOSURE DURING PREGNANCY 4 0.0000
990 BREAST CANCER 4 0.0000
991 DEVICE ISSUE 3 0.0000
992 NO ADVERSE EVENT 6 0.0000